Zidesamtinib
Zidesamtinib (NVL-520) is a potent, selective, orally active and brain-penetrant inhibitor of diverse ROS1 fusions and resistance mutations, with IC50s of 0.7 and 7.9 nM for wild-type ROS1 and ROS1 G2032R, respectively, and spares TRK inhibition. Zidesamtinib can be used for the research of cancer[1].
Product Specifications
CAS Number
[2739829-00-4]
Product Name Alternative
NVL-520; NUV-520
UNSPSC
12352005
Target
ROS Kinase
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zidesamtinib.html
Purity
99.55
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 65°C)
Smiles
CCN1C2=C(C=N1)CC3=NN(C)N=C3C4=CC=C(F)C=C4[C@H](OC5=C(N)N=CC2=C5)C
Molecular Formula
C22H22FN7O
Molecular Weight
419.45
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
B7-1 Protein, Human, Recombinant (ECD, His & AVI Tag), Biotinylated
B7-1 Protein, Human, Recombinant (ECD, His & AVI Tag), Biotinylated
RNU6-6 CRISPR All-in-one AAV vector set (with saCas9)(Human)